Funding for this research was provided by:
Economic and Social Research Council (+4 PhD Studentship)
Bill and Melinda Gates Foundation (OPP1082114)
Global Fund to Fight AIDS, Tuberculosis and Malaria (TNZ-405-GO4-H, TNZ-911-G14-S)
Received: 8 June 2018
Accepted: 30 November 2018
First Online: 10 December 2018
Ethics approval and consent to participate
: Ethical approvals for the 2016 HIV serological survey and the PIRL study were obtained from the National Institute for Medical Research, Tanzania (reference no. NIMR/HQ/R.8c/Vol.II/436 and MR/53/100/450), and the London School of Hygiene and Tropical Medicine (Project ID #8852). Informed written consent was obtained from all participants. Parental written consent was additionally obtained for participants < 18 years of age.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.